HIV-1 drug resistance mutations emerging on darunavir therapy in PI-naive and -experienced patients in the UK

BACKGROUND: Darunavir is considered to have a high genetic barrier to resistance. Most darunavir-associated drug resistance mutations (DRMs) have been identified through correlation of baseline genotype with virological response in clinical trials. However, there is little information on DRMs that a...

Descripción completa

Detalles Bibliográficos
Autores principales: El Bouzidi, Kate, White, Ellen, Mbisa, Jean L., Sabin, Caroline A., Phillips, Andrew N., Mackie, Nicola, Pozniak, Anton L., Tostevin, Anna, Pillay, Deenan, Dunn, David T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5181398/
https://www.ncbi.nlm.nih.gov/pubmed/27856703
http://dx.doi.org/10.1093/jac/dkw343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5181398/
https://www.ncbi.nlm.nih.gov/pubmed/27856703
http://dx.doi.org/10.1093/jac/dkw343

Ejemplares similares